Dexmedetomidine may be renoprotective by reducing ischemia-reperfusion injury, according to the investigators. Dexmedetomidine may reduce the odds of delayed graft function following ...

BXCL501 is an oral thin film formulation of dexmedetomidine, a selective alpha-2a receptor agonist. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to BXCL501 ...

The researchers found that dexmedetomidine reduced the etomidate-induced sustained increase in α5 γ-aminobutyric acid type A receptor cell-surface expression (etomidate: 146.4 ± 51.6%; etomidate + ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Dexmedetomidine Injection, USP in ...

Please provide your email address to receive an email when new articles are posted on . Dexmedetomidine may be an acceptable sedative to administer during dermatologic and cosmetic surgical procedures ...

Please provide your email address to receive an email when new articles are posted on . DALLAS — Critically ill patients undergoing mechanical ventilation in the ICU who received early sedation with ...

Objectives: Although generally effective for sedation during noninvasive procedures, dexmedetomidine as the sole agent has not been uniformly successful for invasive procedures. To overcome some of ...

A study published in the June 2011 issue of the Annals of Pharmacotherapy indicates that increasing doses of the drug dexmedetomidine may not enhance sedation in critically ill patients, according to ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Dexmedetomidine Sales, Price Analysis, & Sales Forecast - 2017" report to their offering. Find out the sales of ...

Outcomes for mechanically ventilated adults with sepsis receiving light sedation were the same whether they received dexmedetomidine or propofol, according to data from a 13-center randomized, ...